Lemaitre Vascular (LMAT) Research & Development (2010 - 2026)
Lemaitre Vascular (LMAT) reported Research & Development of $4.1 million for Q1 2026, down 0.85% year-over-year from $4.1 million in Q1 2025, and up 14.92% quarter-over-quarter from $3.5 million in Q4 2025.
Lemaitre Vascular (LMAT) Research & Development (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Research & Development data on file, last reported at $4.1 million in Q1 2026.
- Research & Development for Q1 2026 came in at $4.1 million, down 0.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 million (down 9.9% YoY), and the FY2025 annual result was $14.1 million, down 9.65% from the prior year.
- Research & Development climbed to $4.1 million in Q1 2026 per LMAT's latest filing, from $3.5 million in the prior quarter.
- Over five years, Research & Development peaked at $4.5 million in Q2 2023 and troughed at $2.9 million in Q1 2022.
- A 5-year average of $3.8 million and a median of $3.7 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2025: Research & Development jumped 34.97% in 2023, then dropped 18.76% in 2025.
- A 5-year view of Research & Development shows it stood at $3.6 million in 2022, then increased by 22.43% to $4.4 million in 2023, then declined by 16.85% to $3.6 million in 2024, then fell by 2.35% to $3.5 million in 2025, then rose by 14.92% to $4.1 million in 2026.
- Business Quant data shows LMAT's Research & Development at $4.1 million in Q1 2026, $3.5 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 94.27 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 15.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 189.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 98.66 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 139.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | 4.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.06 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Mar 31, 2025 | 4.10 Mn |
| Dec 31, 2024 | 3.62 Mn |
| Sep 30, 2024 | 3.66 Mn |
| Jun 30, 2024 | 4.28 Mn |
| Mar 31, 2024 | 4.09 Mn |
| Dec 31, 2023 | 4.35 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 4.52 Mn |
| Mar 31, 2023 | 3.88 Mn |
| Dec 31, 2022 | 3.55 Mn |
| Sep 30, 2022 | 3.46 Mn |
| Jun 30, 2022 | 3.35 Mn |
| Mar 31, 2022 | 2.93 Mn |
| Dec 31, 2021 | 3.46 Mn |
| Sep 30, 2021 | 2.85 Mn |
| Jun 30, 2021 | 2.65 Mn |